OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance
Yihang Gao, Chongchong Feng, Jingru Ma, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116048-116048
Closed Access | Times Cited: 8

Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity
Vincent Rossi, Sarah E. Nielson, Ariana Ortolano, et al.
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 4

Therapeutic Potential of PRMT1 as a Critical Survival Dependency Target in Multiple Myeloma
Tabish Hussain, Sharad Awasthi, Fauzia Shahid, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Cartilage Oligomeric Matrix Protein Promotes Radiation Resistance in Non-Small Cell Lung Cancer In Vitro
Kaitlyn E. Reno, Alicia Costa-Terryll, S. H. Park, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2465-2465
Open Access

PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
Qiaoxi Xia, Rujia Zhong, Jingfang Zheng, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115484-115484
Open Access

Research progress on N6-methyladenosine and non-coding RNA in multiple myeloma
Xiaoqi Sun, Yongming Zhou, Wenwei Zhu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Role of N6‐methyladenosine RNA modification in cancer
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2

PRMT1 Promotes the Self‐renewal of Leukemia Stem Cells by Regulating Protein Synthesis
Min Zhou, Yi Huang, Ping Xu, et al.
Advanced Science (2024)
Open Access | Times Cited: 2

RNA methylation, homologous recombination repair and therapeutic resistance
Yu Bai, Hanlin Zhao, Haijun Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115409-115409
Open Access | Times Cited: 5

Comparative physiological, biochemical and transcriptomic analyses to reveal potential regulatory mechanisms in response to starvation stress in Cipangopaludina chinensis
Chang Yuan, Kangqi Zhou, Xianhui Pan, et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics (2024) Vol. 52, pp. 101279-101279
Open Access | Times Cited: 1

Regulation of m6A Methylome in Cancer: Mechanisms, Implications, and Therapeutic Strategies
Poshan Yugal Bhattarai, Garam Kım, Dibikshya Bhandari, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 66-66
Open Access | Times Cited: 3

KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN
Meng Yu, Wenwen Yang, Jinchao Li, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22084-e22084
Open Access | Times Cited: 1

Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action
Piotr Kulig, Karolina Łuczkowska, Estera Bakinowska, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 84-84
Open Access | Times Cited: 1

The Role of PRMT1 in Cellular Regulation and Disease: Insights into Biochemical Functions and Emerging Inhibitors for Cancer Therapy
Shenglin Ma, Shuhua Yi, Hui Zou, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 204, pp. 106958-106958
Open Access

Page 1

Scroll to top